Learn About Our Convalescent COVID-19 Plasma Donors

Plasma from convalescent COVID-19 patients has been all over the news as a proposed treatment for coronavirus, with the hope that antibodies in the plasma can neutralize the virus and prevent entry into cells. While studies into the safety and effectiveness of this treatment approach are ongoing, convalescent plasma is also needed to drive research…

Read more

Now Available: PBMC from COVID-19 Patients

Human PBMC hold a vast amount of untapped information relevant to immunology, toxicology, inflammation, vaccination, and other areas of study related to the human immune response. We’ve added to our growing list of disease-state PBMC with products collected from donors with a history of SARS-CoV-2 infection, the novel coronavirus.   Peripheral Blood Mononuclear Cells from…

Read more

All in the Autoimmunity Family: Antigen-Specific T Cells

If you haven’t noticed already, our collection of antigen-specific T cells is growing quickly, specifically in the family of autoimmune diseases! Our current available inventory includes T cells that are specific for antigens believed to be responsible for tissue damage in multiple sclerosis, diabetes, and vitiligo. Learn how you can apply these unique cells to…

Read more

Key Biologics and Astarte Biologics Rebrand as Cellero and Announce Completion of Phase One of $50 Million Multi-Year Expansion Plan

New brand and expansion reflect the company’s mission to support the development and delivery of tomorrow’s treatments and cures. MEMPHIS, TN and BOTHELL, WA – May 12, 2020 – Key Biologics and Astarte Biologics, together the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today…

Read more

Unlocking Cures in the New Decade

Welcome customers, partners, and colleagues to the new Cellero website! On behalf of Key Biologics and Astarte Biologics, I’d like to introduce you to our new brand. My name is Jeff Allen, CEO of Cellero. Over the past two years, the Key Biologics and Astarte Biologics teams have been working tirelessly to combine two valued,…

Read more

Key Biologics Joins the Fight Against COVID-19

Launches new program to supply blood products from COVID-19 convalescent donors LOWELL, MA and MEMPHIS, TN – April 29, 2020 – Key Biologics and Astarte Biologics, together the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced the launch of an IRB-approved initiative to…

Read more